Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001199397.3(NEK1):c.1021G>A(p.Ala341Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,527,934 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
NEK1 (HGNC:7744): (NIMA related kinase 1) The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Computational evidence support a benign effect (MetaRNN=0.0074309707).
BP6
Variant 4-169562196-C-T is Benign according to our data. Variant chr4-169562196-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 266046.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=6}.
BS2
High Homozygotes in GnomAdExome4 at 8 AR,Digenic gene
Likely benign, criteria provided, single submitter
clinical testing
GeneDx
Aug 06, 2020
This variant is associated with the following publications: (PMID: 28935222, 28089114, 30755392) -
Uncertain significance, criteria provided, single submitter
clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Jul 02, 2020
The NEK1 c.1021G>A; p.Ala341Thr variant (rs189186475) has not been reported in the medical literature to be associated with a skeletal dysplasia. However, it has been reported in individuals with motor neuron disease and amyotrophic lateral sclerosis, and also in healthy controls (Black 2016, Nguyen 2018). Furthermore, this variant has been reported to co-occur with a pathogenic TARDBP variant in a patient with motor neuron disease (Black 2016). The p.Ala341Thr variant is listed in ClinVar (Variation ID: 266046), and is observed in the general population with an overall allele frequency of 0.17% (310/179350 alleles) in the Genome Aggregation Database. The alanine at position 341 is highly conserved, but computational analyses (SIFT: damaging, PolyPhen-2: tolerated) predict conflicting effects of this variant on protein structure/function. This variant is also located adjacent to the exon-intron junction, but splicing algorithms (Alamut 2.11) are inconclusive on the variant's impact on the nearby canonical splice acceptor site. Due to limited information, the clinical significance of the p.Ala341Thr variant is uncertain at this time. References: Black H et al. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging. 2017; 51:178.e11-178.e20. Nguyen HP et al. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging. 2018 Jan;61:255.e1-255.e7. -
Uncertain significance, criteria provided, single submitter
clinical testing
Eurofins Ntd Llc (ga)
Oct 12, 2015
- -
Likely benign, criteria provided, single submitter
clinical testing
CeGaT Center for Human Genetics Tuebingen
Dec 01, 2022
NEK1: BP4 -
Short-rib thoracic dysplasia 6 with or without polydactyly Uncertain:1Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Jan 26, 2024
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Jan 13, 2018
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Uncertain significance, criteria provided, single submitter
clinical testing
Center for Personalized Medicine, Children's Hospital Los Angeles
-
- -
Motor neuron disease Uncertain:1
Uncertain significance, criteria provided, single submitter
case-control
Centre for Genomic and Experimental Medicine, University of Edinburgh
Aug 31, 2016
- -
NEK1-related disorder Benign:1
Likely benign, no assertion criteria provided
clinical testing
PreventionGenetics, part of Exact Sciences
Jul 28, 2022
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children